MEITAV INVESTMENT HOUSE LTD
Position in NRSN — NeuroSense Therapeutics Ltd.
CIK 1398346
BENE-BERAQ, L3
Position in NRSN
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$30,200
-$560 QoQ
Shares Held
40,000
0.0% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
13 quarters on record
Common Shares in NRSN Over Time
Shares Held
Position Value (USD)
All Filings in NRSN
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,200 | 40,000 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $30,760 | 40,000 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $50,000 | 40,000 | Shares | Defined | 2025-10-29 | |
| 2025-06-30 | $75,600 | 40,000 | Shares | Defined | 2025-07-23 | |
| 2025-03-31 | $37,200 | 40,000 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $48,000 | 40,000 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $50,800 | 40,000 | Shares | Defined | 2024-10-28 | |
| 2024-06-30 | $44,800 | 40,000 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $91,000 | 50,000 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $74,575 | 95,000 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $67,450 | 95,000 | Shares | Defined | 2023-10-30 | |
| 2023-06-30 | $141,550 | 95,000 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $163,400 | 95,000 | Shares | Defined | 2023-05-11 | |
| No filing history on record for this holder in this stock. | ||||||